Indication · Cardiology
Pulmonary embolism and deep vein thrombosis
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
623
Cleared or approved since 2000
PMA and De Novo
11
Higher-risk or first-of-kind devices
Breakthrough devices
2
Authorized through June 30, 2026
Recruiting device trials
32
256 device trials in all
Breakthrough-designated devices
- GORE® VIABAHN® FORTEGRA Venous StentW. L. Gore & Associates, Inc. · 2026
1 more devices with a free account
Devices
623 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- VICI VENOUS STENT System
Boston Scientific Corporation · PMA · Stent, Iliac Vein · newest 2021 · 6 decisions
59 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Pilot Study Evaluating Catheter Directed Thrombolysis Device in Acute Intermediate Risk Pulmonary EmbolismNot yet recruiting
Flow Medical Solutions, Inc.Not on our public-company list
NCT07681154 · 20 participants (planned) · Start Nov 2026 · Primary completion May 2027
Device: Thrombolysis Catheter · For: Pulmonary Embolism (PE); Pulmonary Embolism With Right Ventricle Enlargement
Sites: Talca, Chile
255 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Sleeve, Limb, Compressible (JOW)245
- Peripheral Mechanical Thrombectomy With Aspiration (QEW)79
- Aspiration Thrombectomy Catheter (QEZ)75
- Filter, Intravascular, Cardiovascular (DTK)43
- Plasma, Coagulation Control (GGN)42
- Mechanical Thrombolysis Catheter (QEY)35
- Stocking, Medical Support (To Prevent Pooling Of Blood In Legs) (DWL)27
- Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control (DAP)22
- Catheter, Embolectomy (DXE)20
- Fibrin Split Products (GHH)7
- Test, Factor V Leiden Mutations, Genomic Dna Pcr (NPQ)6
- Stent, Iliac Vein (QAN)6
- Test, Factor Ii G20210a Mutations, Genomic Dna Pcr (NPR)4
- Ultrasound, Infusion, System (NUI)3
- Vacuum Syringe (PUR)2
- Anti-Factor Xa Activity Test System, Apixaban (QLU)2
- System, Mass Spectrometry, Multiplex Genotyping, Hereditary Thrombophilia Related Mutations (PHJ)1
- Short-Term Intravascular Filter Catheter (PNS)1
- Laser-Powered Inferior Vena Cava Filter Retrieval Catheter (QRJ)1
- Stent, Vena Cava (QTL)1
- Thrombectomy Whole Blood Return System (SHJ)1
Research
- Device studies on pulmonary embolism across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.